Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1

Gastroenterology

Volumn 121, Issue 4, 2001, Pages 915-930

  Reynaert, Hendrik ^a   Vaeyens, Freya ^a   Qin, Hong ^a   Hellemans, Karine ^a   Chatterjee, Nirjhar ^a   Winand, Dominique ^a   Quartier, Erik ^a   Schuit, Frans ^a   Urbain, Daniel ^a   Kumar, Ujendra ^a   Patel, Yogesh C ^a   Geerts, Albert ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; MESSENGER RNA; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLOOD VESSEL TONE; CELL ACTIVATION; CONTROLLED STUDY; GENE EXPRESSION; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING;

EID: 0034788301     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.27971     Document Type: Article

References (79)

1. The hepatic circulation in health and disease: Report of a single-topic symposium
2. Intrahepatic modulation of portal pressure and its role in portal hypertension
3. Hepatic stellate (ITO) cells: Expanding roles for a liver-specific pericyte
4. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide
5. Transjugular intrahepatic portosystemic shunt
6. Pharmacological treatment of portal hypertension: An evidence-based approach
7. Endoscopic treatments for portal hypertension
8. The role of portosystemic shunting in the management of portal hypertension
9. Pharmacological treatment of portal hypertension: Present and future
10. Somatostatin or octreotide in acute variceal bleeding
11. Molecular pharmacology of somatostatin receptor subtypes
12. Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract
13. Somatostatin and its receptor family
14. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat
15. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats
16. Glucagon hinders the effects of somatostatin on portal hypertension. A study in rats with partial portal vein ligation
17. Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats
18. Vascular actions of octreotide in the portal hypertensive rat
19. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: A double-blind hemodynamic investigation
20. Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats
21. Purification of rat hepatic stellate cells by side scatter-activated cell sorting
22. Class VI intermediate filament protein nestin is induced during activation of rat hepatic stellate cells
23. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
24. DNA sequencing with chain-terminating inhibitors
25. Formation of normal desmin intermediate filaments in mouse hepatic stellate cells requires vimentin
26. Differential regulation of somatostatin receptors types 1-5 in rat aorta after angioplasty
27. Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts
28. Microvascular pericyte contractility in vitro: Comparison with other cells of the vascular wall
29. Selective suppression of insulin-induced proliferation of cultured human hepatoma cells by somatostatin
30. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry
31. Cloning and expression of a rat somatostatin receptor enriched in brain
32. Expression cloning of a rat brain somatostatin receptor cDNA
33. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain
34. Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat-storing cells by Northern hybridization analysis
35. Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: Quantitative analysis by double-label immunofluorescence confocal microscopy
36. Enzymatic release of oligosaccharides from glycoproteins for chromatochraphic and electrophoretic analysis
37. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
38. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus
39. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells
40. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo
41. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
42. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man
43. Effects of somatostatin on cultured human mesangial cells
44. Identification and characterization of subtype selective somatostatin receptor agonists
45. Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions
46. Immunocytochemical study on the liver innervation in patients with cirrhosis
47. Endothelin, a potent peptide agonist in the liver
48. Gene expression of endothelin-1 and ET(A) and ET(B) receptors in human cirrhosis: Relationship with hepatic hemodynamics
49. Vasoactive effect of endothelin-1 on rat liver in vivo
50. Activation of rat hepatic stellate cells in culture is associated with increased sensitivity to endothelin 1
51. Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells
52. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats
53. Regulation of endothelin-1 action on the perused rat liver
54. Daily profile of plasma endothelin-1 and -3 in preascitic cirrhosis: Relationships with the arterial pressure and renal function
55. Endothelin-1 induces direct constriction of hepatic sinusoids
56. Morphological study of endothelin-1-induced contraction of cultured hepatic stellate cells on hydrated collagen gels
57. Action of endothelins on hepatic stellate cells
58. Octreotide and its effects on portal circulation
59. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin
60. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension
61. Octreotide prevents postprandial splanchnic hyperemia in patients with portal hypertension
62. Effect of somatostatin on oesophageal variceal pressure assessed by direct measurement
63. Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: A randomized, double-blind crossover study
64. The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis
65. Insulin resistance and delayed clearance of peptide hormones in cirrhotic rat liver
66. Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans
67. Local arterial vasoconstriction induced by octreotide in patients with cirrhosis
68. Somatostatin-induced contraction of human isolated saphenous vein involves sst2 receptor-mediated activation of L-type calcium channels
69. Somatostatin receptor subtype expression and function in human vascular tissue
70. Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1)
71. 2+ current modulated by cGMP-dependent protein kinase
72. 2+ currents in rat insulinoma 1046-38 cells
73. Somatostatin receptor subtype SSTR2 mediates the inhibition of high voltage activated calcium channels by somatostatin and its analogue SMS201-995
74. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)
75. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)
76. Rho-stimulated contractility drives the formation of stress fibers and focal adhesions
77. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1
78. Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rhokinase-mediated alterations in the acto-myosin cytoskeleton
79. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): Subtype selective internalization or upregulation